A panelist highlights that updated COMMANDS trial data demonstrate luspatercept’s robust efficacy in erythropoiesis-stimulating agent–naive patients with low-risk myelodysplastic syndrome—achieving ...

A panelist emphasizes that treatment decisions for anemia in low-risk myelodysplastic syndrome should be guided by symptoms ...

Our expert guide to the best in-ear monitors for practice, performance and production, no matter your budget ...

Haematological diseases articles from across Nature Portfolio Haematological diseases are pathological conditions primarily affecting the blood or blood-producing organs. This group of disorders ...

Explore the crucial role of whole blood and prehospital blood transfusion in EMS. This EMS1 topic provides industry news, analysis, protocols, and expert insights to prepare services and ...